** Shares of German medical packaging devices maker
Gerresheimer GXIG.DE rise 8% after Schott Pharma 1SXP.DE
reported a Q3 beat, raised FY sales guidance
** Analyst from Berenberg Victoria Lambert points to signs
of end in destocking as well as gradual recovery in vial orders
** "We think this will help to provide investors with
incremental confidence in seeing a recovery in the vials
market," JP Morgan says
** Shares of Schott Pharma jump 13.4%, on track for best day
ever
** Gerresheimer in July reported Q2 results in line with
expectations and confirmed FY guidance
(Reporting by Anastasiia Kozlova, Amir Orusov and Louis van
Boxel-Woolf)
((Anastasiia.Kozlova@thomsonreuters.com))